Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 60 IN PLASTIC CONTAINER versus DEXTROSE 70 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 60 IN PLASTIC CONTAINER versus DEXTROSE 70 IN PLASTIC CONTAINER.
DEXTROSE 60% IN PLASTIC CONTAINER vs DEXTROSE 70% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose 60% is a hypertonic solution that increases blood glucose levels, providing a source of calories and fluid. It acts as an osmotic diuretic at high concentrations, drawing water from intracellular to extracellular spaces.
Dextrose is a monosaccharide that provides a source of calories and fluid for intravenous administration. It increases blood glucose concentration and is metabolized to carbon dioxide and water, yielding energy.
250 mL of 60% dextrose (150 g) intravenously over 2 hours for hypoglycemia; for parenteral nutrition, dosage individualized based on caloric requirements and glucose tolerance.
Adults: Intravenous infusion, dose dependent on clinical need; typically 500 mL of 70% dextrose (350 g) administered as part of parenteral nutrition at a rate not exceeding 0.5 g/kg/h.
None Documented
None Documented
Approximately 1.5-2.5 hours for exogenous glucose; clinically relevant in monitoring glucose infusion rates in critically ill patients.
30-60 minutes; clinically relevant in hyperglycemic states or renal impairment where glucose clearance is prolonged
Renal: essentially 100% as CO2 and water; negligible unchanged glucose under normal conditions; in hyperglycemia, small amounts (<5%) excreted unchanged in urine when renal threshold exceeded.
100% renal; metabolized to CO2 and water; none excreted unchanged under normal conditions
Category C
Category C
Intravenous Hypertonic Dextrose Solution
Intravenous Hypertonic Dextrose Solution